Systemic Amyloidosis and Kidney Transplantation: An Update

Area of Science:

• Nephrology
• Transplantation immunology
• Internal medicine

Background:

• Amyloidosis involves abnormal protein deposits, frequently causing kidney disease and end-stage kidney disease (ESKD).
• Increased diagnosis and treatment options have led to more amyloidosis patients needing dialysis.
• Kidney transplantation is a viable option for improving survival and quality of life in these patients.

Purpose of the Study:

• To review recent advancements and outcomes of kidney transplantation in amyloidosis-related ESKD.
• To provide guidance on clinical decision-making for managing amyloidosis patients undergoing transplantation.
• To enhance patient selection and post-transplant care strategies for better results.

Main Methods:

• Literature review of recent studies on kidney transplantation for amyloidosis.
• Analysis of outcomes and challenges in pre- and post-transplantation phases.
• Synthesis of current data to inform clinical practice.

Main Results:

• Kidney transplantation can significantly improve outcomes for select amyloidosis patients.
• Challenges exist in timing transplant referrals and managing post-transplant complications.
• Further research is needed to refine management protocols.

Conclusions:

• Kidney transplantation is a key treatment for amyloidosis-related ESKD.
• Careful patient selection and tailored post-transplant management are essential.
• Continued research will optimize transplantation strategies for amyloidosis patients.